Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65a3e0ea84b44bb1b074722eba24c8d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:65a3e0ea84b44bb1b074722eba24c8d6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:65a3e0ea84b44bb1b074722eba24c8d62021-12-02T17:01:16ZErratum: SC83288 is a clinical development candidate for the treatment of severe malaria10.1038/ncomms152732041-1723https://doaj.org/article/65a3e0ea84b44bb1b074722eba24c8d62017-04-01T00:00:00Zhttps://doi.org/10.1038/ncomms15273https://doaj.org/toc/2041-1723Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig.Stefano PegoraroMaëlle DuffeyThomas D. OttoYulin WangRoman RösemannRoland BaumgartnerStefanie K. FehlerLeonardo LucantoniVicky M. AveryAlicia Moreno-SabaterDominique MazierHenri J. VialStefan StroblCecilia P. SanchezMichael LanzerNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-2 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Stefano Pegoraro Maëlle Duffey Thomas D. Otto Yulin Wang Roman Rösemann Roland Baumgartner Stefanie K. Fehler Leonardo Lucantoni Vicky M. Avery Alicia Moreno-Sabater Dominique Mazier Henri J. Vial Stefan Strobl Cecilia P. Sanchez Michael Lanzer Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
description |
Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig. |
format |
article |
author |
Stefano Pegoraro Maëlle Duffey Thomas D. Otto Yulin Wang Roman Rösemann Roland Baumgartner Stefanie K. Fehler Leonardo Lucantoni Vicky M. Avery Alicia Moreno-Sabater Dominique Mazier Henri J. Vial Stefan Strobl Cecilia P. Sanchez Michael Lanzer |
author_facet |
Stefano Pegoraro Maëlle Duffey Thomas D. Otto Yulin Wang Roman Rösemann Roland Baumgartner Stefanie K. Fehler Leonardo Lucantoni Vicky M. Avery Alicia Moreno-Sabater Dominique Mazier Henri J. Vial Stefan Strobl Cecilia P. Sanchez Michael Lanzer |
author_sort |
Stefano Pegoraro |
title |
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
title_short |
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
title_full |
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
title_fullStr |
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
title_full_unstemmed |
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria |
title_sort |
erratum: sc83288 is a clinical development candidate for the treatment of severe malaria |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/65a3e0ea84b44bb1b074722eba24c8d6 |
work_keys_str_mv |
AT stefanopegoraro erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT maelleduffey erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT thomasdotto erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT yulinwang erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT romanrosemann erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT rolandbaumgartner erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT stefaniekfehler erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT leonardolucantoni erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT vickymavery erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT aliciamorenosabater erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT dominiquemazier erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT henrijvial erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT stefanstrobl erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT ceciliapsanchez erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria AT michaellanzer erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria |
_version_ |
1718382211985571840 |